Advanced pharmaceutical development using SPID, a 3D screen‑printing platform enabling novel drug‑delivery formats, accelerated market access, and robust IP protection. Pipeline includes 13 in‑house Advanced Patented Generics and collaborative projects with pharmaceutical, biotech, and academic partners to commercialize innovations for healthcare providers and patients.